Back
Verve Therapeutics Vs. Smith-Midland Industry Stock Comparison
Sell
13
VERV
Verve Therapeutics
Last Price:
5.53
Seasonality Move:
-32.85%
Buy
53
SMID
Smith-Midland
Last Price:
37.12
Seasonality Move:
6.8%
Sell
13
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $5.39. The Score for VERV is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
53
Smith-Midland (SMID)
is a Buy
Is Smith-Midland a Buy, Sell or Hold?
- The current Smith-Midland [SMID] share price is $36.62. The Score for SMID is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SMID is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $5.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing selling pressure, which indicates risk of future bearish movement.
SMID Stock Price Chart
What is Smith-Midland's stock price today?
-
The Smith-Midland share price today is $36.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMID is experiencing buying pressure, which is a positive indicator for future bullish movement.
VERV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 45.62 | Sell |
Chaikin Money Flow: | -1236184 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.81 - 5.95) | Buy |
Bollinger Bands (100): | (5.02 - 6.56) | Sell |
SMID Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.66 | Buy |
Relative Strength Index (14 RSI): | 61.07 | Buy |
Chaikin Money Flow: | 30842 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.64 - 34.92) | Buy |
Bollinger Bands (100): | (29.7 - 36.08) | Buy |
VERV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.58 | Sell |
20-day SMA: | 5.58 | Sell |
50-day SMA: | 6 | Sell |
200-day SMA: | 9.05 | Sell |
8-day EMA: | 5.57 | Sell |
20-day EMA: | 5.61 | Sell |
50-day EMA: | 5.79 | Sell |
200-day EMA: | 8.62 | Sell |
SMID Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.87 | Buy |
20-day SMA: | 33.22 | Buy |
50-day SMA: | 31.84 | Buy |
200-day SMA: | 36.39 | Buy |
8-day EMA: | 33.85 | Buy |
20-day EMA: | 32.95 | Buy |
50-day EMA: | 32.52 | Buy |
200-day EMA: | 32.78 | Buy |
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.
Smith-Midland Earnings Growth & SMID Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Verve Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Smith-Midland Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |